The FDA has approved Precedex (dexmedetomidine HCl, from Hospira) injection for the sedation of non-intubated patients prior to and/or during surgical and other procedures. This approval is based on the results of two randomized, double-blind clinical trials demonstrating the safety and efficacy of Precedex during a variety of surgical and diagnostic procedures, including the fiberoptic intubation of patients who were awake.

Precedex is already indicated for the sedation of intubated and mechanically ventilated patients in the intensive care setting for up to 24 hours.

For more information call (800) 615-0187 or visit www.precedex.com.